Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,025 public trials 3,714 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

NCT06679270

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Familial Partial Lipodystrophy, Genetic Diseases, Inborn, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Flourish Research Boca Raton, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbour, Michigan, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT06060613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • The Angeles Clinic and Research Institute (Melanoma) Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC) Los Angeles, California, United States
  • Stanford Cancer Institute (Melanoma/NSCLC) Stanford, California, United States
  • Orlando Health Cancer Institute (Melanoma/NSCLC) Orlando, Florida, United States
View Trial Details
Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +12 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
  • Southern Oncology Clinical Research Unit Adelaide, Australia
  • Austin Health Melbourne, Australia
View all 19 locations
View Trial Details
Recruiting

MEASuRE: Metreleptin Effectiveness And Safety Registry

NCT02325674

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalised Lipodystrophy, Genetic Diseases, Inborn, +12 more
Locations
  • University Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Atlanta Diabetes Associates Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 28 locations
View Trial Details

Related conditions